FDA Inspection
Saptalis Pharmaceuticals LLCSaptalis Pharmaceuticals LLC – FDA Inspection, Mar 28, 2018
Record Details
This FDA Inspection record concerns Saptalis Pharmaceuticals LLC, with an inspection on March 28, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
- People
- Alice S. Tsao (FDA Associated Person)
- Marisa R. Eschmann (Issuing Officer)
View Company Profile
ID · 73997aa3-6d42-4162-a8ef-f8f8cf2f3ac0
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1046656
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
4- 21 CFR 211.142(b)Storage under appropriate conditions
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.68(a)Calibration/Inspection/Checking not done
- 21 CFR 211.80(a)Written Procedures Not Followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Saptalis Pharmaceuticals LLC
4| Date | Classification | Office | Project area |
|---|---|---|---|
| March 6, 2026 | Not classified | New York District Office | Drug Quality Assurance |
| September 9, 2025 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| March 17, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 30, 2018 | Not classified | New York District Office |
Other documents for Saptalis Pharmaceuticals LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.